Our data indicate that both pluripotent stem cells and HGF may have a beneficial effect in lung fibrosis and may represent the basis of a novel therapeutic approach for patients suffering from UIP/IPF. The gene discussed is HGF; the disease is idiopathic pulmonary fibrosis.